News

To expertly utilize polypharmacy, it is imperative that clinicians stay abreast of new literature, check for drug-drug interactions, and be aware of emerging trends in drug use.

Digital worlds and the fluid social.

The weight-adjusted waist index was a stronger predictor of depressive symptoms than either body mass index or waist circumference.

Highland Park is an excellent example of community recovery from mass tragedies.

The 2024 American Society of Clinical Psychopharmacology Annual Meeting brought together researchers and clinicians to engage in discussion, education, and dissemination of research findings and new methodologies.

Should elected officials have mandated medical evaluations?

How are eating disorders different in LGBTQ+ patients compared with cisgender heterosexual patients? How can you best help manage eating disorders in this patient population?

The FDA did not vote to deny approval of MDMA-assisted psychotherapy on June 4, 2024, contrary to all the buzz in the media saying they did. Learn more here.

"Remember? Remember wanting to play every minute, as if that was why we were born?"

New research found that among 8 first-line antidepressants, bupropion was associated with the least weight gain most consistently.

Psychiatric Times wants to help you, as clinicians, support every patient.

Life, liberty, and the pursuit of happiness or peace, prosperity, and the pursuit of the common good?

Inhalant use disorder is characterized by the intentional inhalation of volatile substances for their psychoactive effects. Learn more about how to help manage this disorder.

Psychiatric Times asked H. Steven Moffic, MD, to share his thoughts on humanitarianism and psychiatry.

Prepare your patients for the Fourth of July with expert tips from Roger Rivera, FNP, PMHNP, DNP, on managing risky behaviors, adherence distractions, PTSD-related triggers, and sensory overload during the holiday.

Kisunla (donanemab-azbt) is now approved by the FDA for adults with early symptomatic Alzheimer disease.

The history of new treatments coming to schizophrenia should serve as a warning...

The movie “Inside Out 2”: good for mental health explorations for individuals of all ages.

Write to us now to be part of our series focused on schizophrenia this month.

An expert offers a critical examination of the "slippery slope" argument.

Let's explore psychological themes in summer movies.

What are your thoughts on the presidential debate?

Here are highlights from the week in Psychiatric Times.

Ideas are a product of their context.

"How free is our will if our fate is decided by our melanin. What is the meaning of Black lives when so many people don’t think we matter?"

H. Steven Moffic, MD, recaps his vacation and the impact it had on his state of mind.

What questions would you ask the presidential debaters?

While ketamine is a not approved for the treatment of depression or chronic pain, clinicians have shown increased interest in using it for these conditions. An FDA workshop is exploring its potential.

June held negative news for psychedelics and an accepted sNDA for brexpiprazole + sertraline for adults with PTSD.

Are you going on vacation this year? Here's why you should.